Evidence map›Paper›PMID 26528651›Full record

Trial reportThe Journal of clinical psychiatry2015

Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.

Paul G Barnett, Wynnie Wong, Abra Jeffers, Sharon M Hall, Judith J Prochaska

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00136812 (Treating Tobacco Dependence in Inpatient Psychiatry), which is not on this map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00136812 nacompletednot on this map

Treating Tobacco Dependence in Inpatient Psychiatry

TypeinterventionalSponsorStanford UniversityRan2006 to 2011Enrolled224ConditionsTobacco Use Cessation, Tobacco Use DisorderArmsstage-tailored intervention
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Pooled it
  3. Print-based self-help interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Trial
  5. Proactive tobacco treatment for veterans with posttraumatic stress disorder.Psychological trauma : theory, research, practice and policy · 2021
    Trial
  6. Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Trial
  7. Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  8. Article
  9. Article
  10. Article
  11. Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paul G Barnett795 Willow Rd, (152 MPD) VA Palo Alto Health Care System, Menlo Park, CA 94025 paul.barnett@va.gov.
Wynnie Wong
Abra Jeffers
Sharon M Hall
Judith J Prochaska
University of California, San Francisco · USStanford University · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 1994 to 2014
$28.2M
Treatment of Complex Patients: Emphasis on NicotineK05DA016752 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 2003 to 2012
$1.1M
Treating Tobacco Dependence in Inpatient PsychiatryK23DA018691 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2005 to 2009
$769k
NIDA NIH HHS K05 DA016752NIDA NIH HHS K23 DA018691NIDA NIH HHS P50 DA009253NIDA NIH HHS P50 DA09253
6 · The paper itself

Abstract

objectiveWe examined the cost-effectiveness of smoking cessation treatment for psychiatric inpatients.

methodSmokers, regardless of intention to quit, were recruited during psychiatric hospitalization and randomized to receive stage-based smoking cessation services or usual aftercare. Smoking cessation services, quality of life, and biochemically verified abstinence from cigarettes were assessed during 18 months of follow-up. A Markov model of cost-effectiveness over a lifetime horizon was constructed using trial findings and parameters obtained in a review of the literature on quit and relapse rates and the effect of smoking on health care cost, quality of life, and mortality.

resultsAmong 223 smokers randomized between 2006 and 2008, the mean cost of smoking cessation services was $189 in the experimental treatment group and $37 in the usual care condition (P < .001). At the end of follow-up, 18.75% of the experimental group was abstinent from cigarettes, compared to 6.80% abstinence in the usual care group (P < .05). The model projected that the intervention added $43 in lifetime cost and generated 0.101 additional quality-adjusted life-years (QALYs), an incremental cost-effectiveness ratio of $428 per QALY. Probabilistic sensitivity analysis found the experimental intervention was cost-effective against the acceptance criteria of $50,000/QALY in 99.0% of the replicates.

conclusionsA cessation intervention for smokers identified in psychiatric hospitalization did not result in higher mental health care costs in the short-run and was highly cost-effective over the long-term. The stage-based intervention was a feasible and cost-effective way of addressing the high smoking prevalence in persons with serious mental illness.

trial registrationClinicalTrials.gov identifier: NCT00136812.

Indexed as

AdultCost-Benefit AnalysisFemaleHealth Care CostsHealth ServicesHospitalizationHumansInpatientsMaleMarkov ChainsMental DisordersSmokingSmoking Cessation

Identifiers

PMID26528651
PMCPMC4988964
OpenAlexW2187071858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.